Prof. Wei Dai attended China Medical University for her Bachelor’s degree and obtained her Master’s degree in Bioinformatics from the University of Manchester in the UK. In 2011, she finished her PhD in Cancer Bioinformatics at the Department of Surgery and Cancer, Faculty of Medicine at Imperial College London in the UK. She was awarded the British Association of Cancer Research (BACR) Gordon Hamilton-Fairley Young Investigator Award for her PhD study on methylation prognostic biomarkers for epithelial ovarian cancer. She joined the Department of Clinical Oncology as a Postdoctoral Research Fellow in Prof Maria Lung’s group in 2013 and became a Research Assistant Professor in 2016. Her research interests include (1) bioinformatics and system biology approaches for understanding pathogenesis and progression in nasopharyngeal carcinoma and esophageal squamous cell carcinoma; (2) the integration of genomic, epigenomic changes, and clinical data to identify the biomarkers for cancer metastasis, relapse, and drug resistance; and (3) the development of bioinformatics tools for identifying the genomic alterations in liquid biopsies.